Medical Schemes Act, 1998 (Act No. 131 of 1998)

Regulations

Regulations in terms of the Medical Schemes Act

Annexures

Annexure B : Explanatory notes and conditions for Annexure B

Purchase cart Previous page Return to chapter overview Next page

 

(1)In respect of items l (a)(i) and l (a)(ii), for banks that are subsidiaries of foreign banks, the foreign parent's capital may not be taken into account.

 

(2)The sum of deposits in categories l (a)(i) and l (a)(ii) shall not be less than 20%.

 

(3)Total amounts in categories l (b) and 2 (b) are subject to an aggregate maximum of 15%.

 

(4)The aggregate of amounts in categories l (a)(ii), 2 (a)(ii) and 2 (a)(xiii) shall be subject to a maximum limit of 30%.

 

(5)The total exposure allowance per bank, being the aggregate of amounts included in categories 1 (a)(i) and 2 (a)(xi) is subject to an aggregate maximum of 35%.

 

(6)The total exposure allowance per bank, being the aggregate of amounts included in categories 1 (a)(ii) and 2 (a)(xii) is subject to an aggregate maximum of 10%.

 

(7)The total exposure allowance for all banks within categories 1 (a)(ii) and 2 (a)(xii) is subject to an aggregate maximum of 30%.

 

(8)Unit trusts and policies of insurance may not be utilised to circumvent the limitations of these regulations. Medical schemes are required to demonstrate on a "look through" basis that such avenues have not been utilised to bypass the limitations imposed by Annexure B.